Recce Pharmaceuticals advances R327 Gel towards Phase 3 after promising Phase II trial
Recce Pharmaceuticals Limited has announced significant success in its Phase II trial of RECCE 327 topical gel (R327G), a synthetic anti-infective designed to treat acute ... Read More
FDA approves EMBLAVEO to combat complicated intra-abdominal infections with limited treatment options
The U.S. Food and Drug Administration (FDA) has granted approval for EMBLAVEO (aztreonam and avibactam), marking a significant milestone in the fight against complicated intra-abdominal ... Read More
Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to ... Read More
Mid Yorkshire NHS Trust adopts Ondine’s Steriwave to combat surgical site infections
Mid Yorkshire Teaching NHS Trust has taken a significant step forward in the battle against surgical site infections (SSIs) by approving the commercial adoption of ... Read More